glp-1 weight loss drugs tirzepatide semaglutide Variable weight-loss and cardiovascular benefits were seen with in a systematic review and network meta-analysis, but effects on quality of life were less clear. https://www.medpagetoday.com/primarycare/obesity/122142 Weight Loss Drug Shake Up:

For comparison, microdosing tirzepatide has its own chart and dedicated following

Influencers call them a cheaper, chewable alternative to semaglutide, and search volume echoes the buzz

Patnoe said diabetes care and education specialists should screen patients with diabetes for eating disorder thoughts and behaviors before and after starting GLP-1 therapy, and therapy should start at the lowest dose possible where hunger signals are maintained, and titration should be slow

Lastly as the majority of GLP-1 RAs in this study were semaglutide, this may not apply to all GLP-1 RAs and additionally, because the analysis excluded over 26,000 patients who could not be matched, the results may not apply to the full spectrum of patients taking these drugs in the real world, particularly those with more complex health profiles. MNT spoke with David I